Dare Bioscience, Inc. Loans Payable, Noncurrent
Dare Bioscience, Inc. (DARE) had Loans Payable, Noncurrent of $4.44 million as of 2016-12-31, per its 10-Q filed 2017-08-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermLoansPayable · last filed 2017-08-14
- 2016-12-31: Loans Payable, Noncurrent $4.44M.
- 2016-09-30: Loans Payable, Noncurrent $6.55M.
- 2016-06-30: Loans Payable, Noncurrent $8.65M.
- 2016-03-31: Loans Payable, Noncurrent $10.69M.
| Period end | Loans Payable, Noncurrent |
|---|---|
| 2016-12-31 | $4.44M 10-Q · filed 2017-08-14 |
| 2016-09-30 | $6.55M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $8.65M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $10.69M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $12.67M 10-K/A · filed 2017-06-13 |
| 2015-09-30 | $10.53M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $11.83M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $13.58M 10-Q · filed 2015-05-06 |
| 2014-09-30 | $587.00K 10-Q · filed 2014-11-13 |
| 2014-06-30 | $1.45M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $2.30M 10-Q · filed 2014-05-27 |
| 2013-12-31 | $3.12M 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |